Informations sur le produit
Nom :
CK 1827452O
Synonymes :
- Ck-1827452
- Methyl 4-[[2-fluoro-3-[N′-(6-methylpyridin-3-yl)ureido]phenyl]methyl]piperazine-1-carboxylate
- Omecamtiv mecarbil
- 1-Piperazinecarboxylic acid, 4-[[2-fluoro-3-[[[(6-methyl-3-pyridinyl)amino]carbonyl]amino]phenyl]methyl]-, methyl ester
Description :
CK 1827452O is a small-molecule drug that increases the glomerular filtration rate (GFR) by inhibiting the Na+,K+-ATPase. CK 1827452O has been shown to be effective in treating congestive heart failure, which may be due to its ability to increase cardiac output and reduce left ventricular end-diastolic pressure. CK 1827452O also acts on the cytosolic calcium concentration and systolic pressure, as well as natriuretic and inotropic drugs. These effects are due to its inhibition of Na+,K+-ATPase, which leads to an increase in intracellular calcium and an increase in cAMP levels.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
401.43 g/mol
Formule :
C20H24FN5O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
